Cereno Scientific’s Board of Directors have decided to carry out a rights issue of units of approximately SEK 110 million and intends to change marketplace to Nasdaq First North Growth Market
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE FURTHER REGISTRATION OR ANY OTHER MEASURES. The Board of Directors of Cereno Scientific AB (publ) ("Cereno Scientific" or the "Company") has, with authorization from the annual general meeting on 1 June, 2022, decided to carry out